Search Results - "Fitzgerald, Timothy"

Lymphadenopathy in Concurrent Head and Neck Malignancies.

Authors: Fitzgerald, Timothy Rigsby, Ryan K. Kaushik, Shashank

Source: Case Reports in Radiology. 1/16/2026, Vol. 2026, p1-11. 11p.

This result is not displayed to guests.
Login for full access.

Comparative analysis of persistence and remission with guselkumab versus secukinumab and ixekizumab in the United States.

Authors: Zhdanava, Maryia Fitzgerald, Timothy Pilon, Dominic et al.

Source: Journal of Dermatological Treatment. Dec2024, Vol. 35 Issue 1, p1-10. 10p.

INFRASTRUCTURE FOR THE ENERGY TRANSITION.

Authors: Fitzgerald, Timothy¹

Source: Case Western Reserve Law Review. Fall2024, Vol. 75 Issue 1, p19-68. 50p.

Response to the Letter to the Editor: Long-Term Psoriasis Control with Guselkumab, Adalimumab, Secukinumab, or Ixekizumab in the USA.

Authors: Fitzgerald, Timothy Zhdanava, Maryia Pilon, Dominic et al.

Source: Dermatology & Therapy. Nov2023, Vol. 13 Issue 11, p2917-2923. 7p.

Automated analysis of low‐field brain MRI in cerebral malaria.

Authors: Tu, Danni Goyal, Manu S. Dworkin, Jordan D. et al.

Source: Biometrics; Sep2023, Vol. 79 Issue 3, p2417-2429, 13p

The Administration of Justice in Medieval Egypt: From the Seventh to the Twelfth Century By Yaacov Lev.

Authors: Fitzgerald, Timothy J¹ (AUTHOR) fitzgetj@jmu.edu

Source: Journal of Islamic Studies. Sep2023, Vol. 34 Issue 3, p414-417. 4p.

Regulatory capture in a resource boom.

Authors: Fitzgerald, Timothy¹ (AUTHOR) timothy.fitzgerald@ttu.edu

Source: Public Choice. Jan2024, Vol. 198 Issue 1/2, p93-127. 35p.

Long-Term Psoriasis Control with Guselkumab, Adalimumab, Secukinumab, or Ixekizumab in the USA.

Authors: Fitzgerald, Timothy Zhdanava, Maryia Pilon, Dominic et al.

Source: Dermatology & Therapy. Apr2023, Vol. 13 Issue 4, p1053-1068. 16p.

Real-World Effectiveness of 9–12 Months of Guselkumab Therapy among Patients with Moderate-to-Severe Plaque Psoriasis in the CorEvitas Psoriasis Registry.

Authors: Armstrong, April W. Fitzgerald, Timothy McLean, Robert R. et al.

Source: Dermatology & Therapy. Feb2023, Vol. 13 Issue 2, p629-640. 12p.

Effectiveness of Guselkumab Therapy among Patients with Plaque Psoriasis with Baseline IGA Score ≥ 2 in the CorEvitas Psoriasis Registry.

Authors: Armstrong, April W. Fitzgerald, Timothy McLean, Robert R. et al.

Source: Dermatology & Therapy. Feb2023, Vol. 13 Issue 2, p487-504. 18p.

Japan, Religion, History, Nation.

Authors: Fitzgerald, Timothy^1,2 (AUTHOR) t.fitzgerald@uq.edu.au

Source: Religions. Jun2022, Vol. 13 Issue 6, pN.PAG-N.PAG. 36p.

Risk of Treatment Discontinuation among Patients with Psoriasis Initiated on Ustekinumab and Other Biologics in the USA.

Authors: Pilon, Dominic Fitzgerald, Timothy Zhdanava, Maryia et al.

Source: Dermatology & Therapy. Apr2022, Vol. 12 Issue 4, p971-987. 17p.

Characteristics of New Biologic Users Among the Moderate-to-Severe Psoriasis Population—Retrospective Cohort Study Leveraging the Modernizing Medicine Data Services Database.

Authors: Fitzgerald, Timothy Near, Aimee M. Kim, Hyunchung et al.

Source: Dermatology & Therapy. Mar2022, Vol. 12 Issue 3, p741-752. 12p.

Cost per responder for guselkumab versus secukinumab in the United States based on a head-to-head trial of moderate to severe plaque psoriasis.

Authors: Teeple, Amanda Fitzgerald, Timothy

Source: Journal of Dermatological Treatment. Fe 2022, Vol. 33 Issue 1, p518-524. 7p.

On-Label Treatment Persistence Through 24 Months Among Patients with Active Psoriatic Arthritis Initiating Guselkumab or Subcutaneous Tumor Necrosis Factor Inhibitors.

Authors: Mease, Philip J. Walsh, Jessica A. Fitzgerald, Timothy P. et al.

Source: Rheumatology & Therapy. Feb2026, Vol. 13 Issue 1, p115-134. 20p.

Religion, Politics, History, and Culture: A Critical Response to Daniel Miller (2014).

Authors: Fitzgerald, Timothy¹ (AUTHOR) timfitz10@yahoo.co.uk

Source: Method & Theory in the Study of Religion. 2020, Vol. 32 Issue 4/5, p386-422. 37p.

This result is not displayed to guests.
Login for full access.

Catalyzing fisheries conservation investment.

Authors: Fitzgerald, Timothy P Higgins, Phoebe R Quilligan, Emma et al.

Source: Frontiers in Ecology & the Environment. Apr2020, Vol. 18 Issue 3, p151-158. 8p.

"What is critical religion?" A Response to Galen Watts and Sharday Mosurinjohn, "Can Critical Religion Play by Its Own Rules?": Journal of the American Academy of Religion, https://doi.org/10.1093/jaarel/lfac045; published 9 July 2022.

Authors: Fitzgerald, Timothy^1,2,3 (AUTHOR) fitzgeraldtimothy6@gmail.com

Source: Method & Theory in the Study of Religion. 2024, Vol. 36 Issue 3/4, p238-266. 29p.